The SpHb tracked changes in hemoglobin satisfactorily during surgery and more accurately estimated the appropriate timing for invasive hemoglobin measurements.
Issued patent further bolsters company’s IP estate, supporting strategic pathway for Pure-Vu System to become standard of care for inpatient colonoscopy.
The patents issued range in subject matter and include coverage of the Axonics clinician programmer, patient remote control, and internal system electronics.